PRA Health Sciences Archives | Be Korea-savvy
PRA Health Sciences Ready to Navigate RACE Act Requirements for Pediatric Oncology

PRA Health Sciences Ready to Navigate RACE Act Requirements for Pediatric Oncology

RALEIGH, N.C., June 18 (Korea Bizwire) — Between 2007-2017, 78 novel adult cancer agents were approved by the U.S. Food and Drug Administration,1 but none of those drugs were researched to determine effectiveness for pediatric cancers. That is about to change on August 18 when the RACE Act – The Research to Accelerate Cures and Equity [...]

PRA Enhances COVID-19 Monitoring Program with Integration of Microsoft Healthcare Bot Service

PRA Enhances COVID-19 Monitoring Program with Integration of Microsoft Healthcare Bot Service

RALEIGH, N.C., June 12 (Korea Bizwire) — PRA Health Sciences, Inc. (NASDAQ: PRAH) announced today the enhancement of its commercial Health Harmony COVID-19 Monitoring Program with the integration of the Microsoft Healthcare Bot service. Users of PRA’s Health Harmony digital platform who enroll in their organization’s COVID-19 Monitoring Program can use the AI-based chatbot, which can [...]

Symphony Health to Provide Free Access to New Metys™ COVID-19 Module for U.S. based Life Sciences Industry During Pandemic

Symphony Health to Provide Free Access to New Metys™ COVID-19 Module for U.S. based Life Sciences Industry During Pandemic

RALEIGH, N.C., April 8 (Korea Bizwire) — PRA Health Sciences (NASDAQ: PRAH) announced today that Symphony Health, a PRA Health Sciences company, will make a 30-day license of its newly released MetysTM COVID-19 Module available to the U.S. life science industry at no charge. The COVID-19 Module within the Metys platform will provide up to three [...]

PRA Health Sciences Expands Remote Clinical Study Support with its Mobile Health Platform During COVID-19 Pandemic

PRA Health Sciences Expands Remote Clinical Study Support with its Mobile Health Platform During COVID-19 Pandemic

RALEIGH, N.C., March 24 (Korea Bizwire) — As a response to the ongoing global COVID-19 pandemic, PRA Health Sciences announced today the expansion of its industry-leading Mobile Health Platform for remote clinical monitoring, adding several new capabilities that address sponsor needs for COVID-19 virtual study support. PRA’s Mobile Health Platform (MHP) engages with patients wherever [...]

PRA Health Sciences Launches COVID-19 Monitoring Program

PRA Health Sciences Launches COVID-19 Monitoring Program

RALEIGH, N.C., March 20 (Korea Bizwire) — PRA Health Sciences announced today the commercial availability of the COVID-19 Monitoring Program, a mobile app-driven, tiered initiative that allows employers, payers, providers and health systems to track the health and wellbeing of individuals who may be asymptomatic, exposed or diagnosed with COVID-19 during the pandemic. Based on [...]

Symphony Health Partners with Datavant for the Industry’s Deepest View of the Patient Journey

Symphony Health Partners with Datavant for the Industry’s Deepest View of the Patient Journey

RALEIGH, N.C., March 11 (Korea Bizwire) — PRA Health Sciences (NASDAQ: PRAH) announced today a partnership between Symphony Health and Datavant that expands the breadth of data available for integration and allows life sciences companies to get the deepest and most holistic view of the patient journey in the commercial market. Symphony Health’s proprietary Synoma® de-identification [...]

PRA Health Sciences, Symphony Health Launch Metys™ National Market Measurement Tool

PRA Health Sciences, Symphony Health Launch Metys™ National Market Measurement Tool

RALEIGH, N.C., Sept. 18 (Korea Bizwire) — PRA Health Sciences (NASDAQ: PRAH) announced today the launch of Symphony Health’s new national market measurement tool – Metys™ (pronounced Met-IS), the only completely integrated, all-in-one market research solution available from a contract research organization (CRO). The first platform of its kind, Metys delivers pharmaceutical market analytics and intelligence [...]

PRA Health Sciences, Inc. Announces Pricing of Secondary Offering and Concurrent Share Repurchase

PRA Health Sciences, Inc. Announces Pricing of Secondary Offering and Concurrent Share Repurchase

RALEIGH, N.C., Sept. 4 (Korea Bizwire) — PRA Health Sciences, Inc. (the “Company”) (NASDAQ: PRAH) today announced the pricing of the previously announced secondary offering of shares of its common stock.  KKR PRA Investors L.P. (the “Selling Stockholder”), has agreed to sell an aggregate of 6,666,684 shares of the Company’s common stock in an underwritten [...]

PRA Health Sciences, Inc. Announces $500 Million Share Repurchase Program

PRA Health Sciences, Inc. Announces $500 Million Share Repurchase Program

RALEIGH, N.C., Sept. 3 (Korea Bizwire) — PRA Health Sciences, Inc. (the “Company”) (NASDAQ: PRAH) today announced that its Board of Directors (the “Board”) has authorized a $500 million share repurchase program, effective immediately.  Under the program, the Company is authorized to repurchase shares of its common stock through open market purchases, privately-negotiated transactions, secondary [...]